Patients missing out on optimum therapy post-MI: Aust study
A big data linkage study shows low rates of dispensing post-discharge and wide variation among hospitals
Almost half the patients hospitalised for acute MI miss out on guideline-recommended dual antiplatelet therapy upon discharge, an Australian study has found.
And among those who were given a P2Y12 inhibitor — clopidogrel, ticagrelor or prasugrel — within one month of leaving hospital, one quarter discontinued the therapy within 12 months, the researchers say.
